S&P 500   2,966.15 (-0.14%)
DOW   26,787.36 (-0.11%)
QQQ   191.09 (-0.01%)
AAPL   235.87 (-0.14%)
FB   183.28 (-0.49%)
MSFT   139.55 (-0.09%)
GOOGL   1,217.77 (+0.17%)
AMZN   1,736.43 (+0.26%)
CGC   18.86 (-2.93%)
NVDA   186.53 (+0.29%)
MU   44.86 (-0.53%)
BABA   171.16 (-1.03%)
GE   8.72 (-0.91%)
TSLA   256.96 (+3.66%)
AMD   30.53 (+2.62%)
T   37.47 (-0.29%)
F   8.82 (+0.46%)
ACB   3.51 (-4.62%)
PRI   121.47 (-0.18%)
NFLX   285.53 (+0.92%)
BAC   29.14 (+0.80%)
GILD   64.51 (+0.81%)
DIS   129.70 (-0.25%)
S&P 500   2,966.15 (-0.14%)
DOW   26,787.36 (-0.11%)
QQQ   191.09 (-0.01%)
AAPL   235.87 (-0.14%)
FB   183.28 (-0.49%)
MSFT   139.55 (-0.09%)
GOOGL   1,217.77 (+0.17%)
AMZN   1,736.43 (+0.26%)
CGC   18.86 (-2.93%)
NVDA   186.53 (+0.29%)
MU   44.86 (-0.53%)
BABA   171.16 (-1.03%)
GE   8.72 (-0.91%)
TSLA   256.96 (+3.66%)
AMD   30.53 (+2.62%)
T   37.47 (-0.29%)
F   8.82 (+0.46%)
ACB   3.51 (-4.62%)
PRI   121.47 (-0.18%)
NFLX   285.53 (+0.92%)
BAC   29.14 (+0.80%)
GILD   64.51 (+0.81%)
DIS   129.70 (-0.25%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 INDIVIOR PLC/SRocket PharmaceuticalsKiniksa PharmaceuticalsKaryopharm TherapeuticsAtreca
SymbolOTCMKTS:INVVYNASDAQ:RCKTNASDAQ:KNSANASDAQ:KPTINASDAQ:BCEL
Price Information
Current Price$3.00$11.77$5.95$10.11$10.02
52 Week RangeHoldBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationHoldBuyBuyBuyBuy
Consensus Price TargetN/A$31.25$31.33$19.33$24.41
% Upside from Price TargetN/A165.51% upside426.61% upside91.23% upside143.59% upside
Trade Information
Market Cap$436.98 million$592.62 million$364.24 million$618.59 million$279.92 million
Beta-0.182.71-1.352.42N/A
Average Volume5,093294,422113,4101,792,911107,605
Sales & Book Value
Annual Revenue$1.01 billionN/AN/A$30.34 millionN/A
Price / Sales0.43N/AN/A20.63N/A
Cashflow$2.11 per shareN/AN/AN/AN/A
Price / Cash1.42N/AN/AN/AN/A
Book Value$0.45 per share$4.47 per share$5.64 per share$3.02 per shareN/A
Price / Book6.67N/AN/A3.35N/A
Profitability
Net Income$275 million$-74,520,000.00$-103,230,000.00$-178,410,000.00N/A
EPS$1.80($1.89)($3.49)($3.14)N/A
Trailing P/E Ratio1.67N/AN/AN/A0.00
Forward P/E Ratio10.00N/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins25.23%N/AN/A-2,138.80%N/A
Return on Equity (ROE)556.86%-42.73%-57.63%-154.75%N/A
Return on Assets (ROA)18.06%-32.71%-51.38%-79.47%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio2.16%0.18%N/A1.46%N/A
Current Ratio1.79%17.48%9.82%6.93%26.46%
Quick Ratio1.70%17.48%9.82%6.93%26.46%
Ownership Information
Institutional Ownership PercentageN/A97.15%30.22%82.58%56.70%
Insider Ownership PercentageN/A41.40%70.63%11.63%N/A
Miscellaneous
Employees9153311133285
Shares Outstanding145.66 million50.35 million54.86 million61.92 million27.95 million
Next Earnings Date11/7/2019 (Estimated)11/6/2019 (Estimated)11/7/2019 (Estimated)11/14/2019 (Estimated)11/12/2019 (Estimated)
OptionableNot OptionableOptionableNot OptionableOptionableNot Optionable
 INDIVIOR PLC/SRocket PharmaceuticalsKiniksa PharmaceuticalsKaryopharm TherapeuticsAtreca

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel